genlabs semaglutide Demand Rising for 'Bootlegged' Weight-Loss Drug Details of failed studies cast

The key periconception safety boundaries remain explicit contraception during treatment, drug-specific discontinuation, and completion of the recommended washout period before conception attempts

Patients taking semaglutide can experience dizziness, fatigue, diarrhea, constipation, gassiness, headache, nausea, vomiting, pain, low blood sugar, less fullness in the face, vivid dreams, hair loss or bloating

Promisingly, the risk conferred is smaller in younger children, and few patients discontinue treatment because of serious adverse effects, supporting the safety of these medications

L., Schloos, J

10.1111/dom.14881 24 HuS.SuX.DengX.WangY